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Annex 1: ENRIECO Inventory Questionnaire 
 
A. Basic Protocol Description (update of www.birthcohorts.net) 
 
A1. Identification 
• Cohort name: 
 
• Principal investigator: 
 
• Contact(s) for environmental exposures:  
 
• Cohort website: 
 
• Key publication(s) of cohort protocol/methods/description: 
  
 
A2. Basic Description  
• Main aim/objectives/focus of cohort: 
 
• Source population 
 nation-based 
 region-based 
 hospital-based 
 selected (high-risk, exposure etc.), describe: 
 other:  
 
• Geographical coverage, please describe: __________________ 
 
• Calendar period of enrolment – calendar years of start and finish: _____________ 
 
• Enrolment - status:  
 completed 
 ongoing 
 planned 
 
• Developmental period of enrolment – give developmental period of start of enrolment:  
 pre-pregnancy 
 pregnancy, give pregnancy week(s)  ________ weeks of pregnancy 
 at birth 
 postnatal, give month(s)    ________ months of age  
 
• Enrolment criteria, please describe in and exclusion criteria: 
 
• Expected number of participants at enrolment when enrolment completed:  
 
_____ mothers _____ fathers  _____ children 
 
 
• Expected duration of follow-up: _______ years 
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A3. Basic Data Collection Scheme 
 
Pregnancy Post natal Type of data collection 
(Give estimate of number of subjects for each period 
where data/samples are available: N=XXX ) 
1st trimester 2nd trimester 3rd trimester 
Birth 
0-6 months 7-18 
months 
18-60 
months 
5-10 years 10+ years 
Questionnaires:          
maternal exposures          
paternal exposures          
offspring exposures          
maternal outcomes          
paternal outcomes          
offspring outcomes          
Biological samples:          
maternal blood          
paternal blood          
cord blood          
offspring blood          
maternal urine          
paternal urine          
offspring urine          
maternal other (hair, nails, saliva, breast 
milk,  etc.) 
         
Paternal other (hair, nails, saliva etc.)          
offspring other (hair, nails, saliva, etc.)          
  4
B. Exposure Assessment 
 
B1. Outdoor Air Pollution  
• Were outdoor air pollution exposures assessed for the members of your cohort? 
 yes 
 not yet, but planned. Please give predicted year of completion: 20______   
 no, please proceed to part B2 
 
• Which air pollutants were/will be assessed (multiple answers possible)? 
 nitrogen dioxide (NO2) 
 nitrogen oxides (NOx) 
 particulate matter < 10 μg in diameter  (PM10) 
 particulate matter < 2.5 μg in diameter (PM2.5) 
 soot content of particulate matter 
 ozone (O3) 
 others: ________________________ 
 
• Which types of exposure assessment were/will be used (multiple answers possible)? 
 dispersion modelling 
 land-use regression modelling 
 routine air monitoring network measurements (e.g. nearest monitor, interpolation) 
 exposure indicator variables (e.g. traffic density; proximity to traffic/industry from  
      geographic information system) 
 questionnaires (e.g. self-reported traffic densities; proximity to traffic or industrial    
      sources; wood smoke exposure). Please describe: ______________________ 
 individual measurements (e.g. personal monitoring, stationary measurements  
      outside/inside participants’ homes). Please describe:___________________ 
 
• Details of the assessments (complete table with pollutant, assessment method, timing, 
and rough number of assessments): 
Type of air pollution assessment Pregnancy (mother) Post natal 
(child) 
Air pollutant Method 1st trim. 2nd 
trim. 
3rd trim. Age 
Number/% 
of the 
cohort 
       
       
  
     
Completed:      
       
       
       
Planned:      
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B2. Indoor Contaminants (for example from combustion sources, cleaning products, or 
any indoor exposures not already included in other sections)  
 
• Were exposures to indoor contaminants assessed for the members of your cohort? 
 yes 
 not yet, but planned. Please give predicted year of completion: 20______   
 no (proceed to part B3) 
 
• Which indoor contaminants were/will be assessed? 
 nitrogen dioxide (NO2)  
 VOCs 
 gas cooking / heating / appliances 
 cleaning products  
 others:  
 
• Which types of exposure assessment were/will be used (multiple answers possible)? 
 modelling 
 individual measurements (e.g. personal monitoring, indoor air monitoring) 
 questionnaires (e.g. use of gas cookers, type of heating system, use of cleaning products) 
 other:  
 
• Details of the assessments (complete table with pollutant/contaminant, assessment 
method, timing, and rough number of assessments): 
Type of indoor contaminant 
assessment 
Pregnancy (mother) Post natal 
(child) 
contaminant Method 1st trim. 2nd 
trim. 
3rd trim. Age 
Number/% 
of the 
cohort 
      
       
       
Completed:       
       
       
       
Planned:      
       
       
       
 
Further description: 
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B3. Water Contamination  
 
• Were water contaminants assessed for the members of your cohort? 
 yes 
 not yet, but planned. Please give predicted year of completion: 20_____   
 no (proceed to part B4) 
 
• Which water contaminants were/will be assessed? 
 disinfection by products 
 pesticides   
 metals 
 endocrine disrupting substances 
 others: __________________________________________________________________ 
 
• Which type of assessment/questionnaire questions are/were used? 
 routine monitoring water concentration data from water companies or government 
 newly collected water concentration data (measurements) 
 questionnaire: 
 information on tap/bottled water ingestion  
 information on coffee, tea and other tap water based beverage ingestion  
 information on swimming habits 
 information on showering/bathing habits 
 personal biomonitoring 
 other:  
 
• Details of the assessments (complete table with pollutant/contaminant, assessment 
method, timing, and rough number of assessments): 
Type of water contaminant 
assessment 
Pregnancy (mother) Post natal (child) 
contaminant Method 1st trim. 2nd 
trim. 
3rd trim. Age 
Number/% of 
the cohort 
      
       
       
Completed      
       
       
       
Planned:      
       
       
       
 
 
Further description: 
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B4. Allergens and biological organisms  
 
• Were exposures to allergens and biological organisms assessed for the members of your cohort? 
 yes 
 not yet, but planned. Please give predicted year of completion: 20____  
 no (proceed to part B5) 
 
• Which allergens and biological organisms were assessed or will be assessed (indicate whether completed or planned)? 
Assessment method Timing of the assessment (please specify) Type of allergens  
Direct measurement from 
house dust or air samples 
Surrogate* 
(please specify) 
During 
pregnancy 
0-1 years 
(up to 12 months)
During Early 
Childhood 
% or N of the 
cohort measured
Mite- Der p       
          Der f       
Pets- Cat       
          Dog       
Other pets (please specify)       
Mold-Cladosporium       
           Penicillium       
           Aspergilus       
           Alternaria       
Other mold allergens       
Cockroach       
Pollen       
Other       
Other bio-contaminant:       
Pests & Vermin       
Endotoxin       
Mold-Eps       
           Glucan       
Other mold species       
Other       
* Please specify the surrogate measures, for example: cat ownership for cat allergen, humidity for mold exposure in general, spore counts for mold allergen, 
season of birth for specific pollen. 
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B5. Heavy Metals  
 
• Was exposure to heavy metals assessed for the members of your cohort? 
 yes 
 not yet, but planned. Please give predicted year of completion: 20_____   
 no (please proceed to part B6) 
 
• Which agents were/will be assessed? 
 mercury (Hg) 
 lead (Pb)   
 cadmium (Cd) 
 arsenic (As) 
 manganese (Mn) 
 total metals spectrum 
 other: __________________________________  
 
• Which type of assessment was/will be used?  
 biological sampling 
 environmental sampling 
 questionnaires 
 occupational exposure / JEM 
 dietary exposure (please specify: _____________________) 
 through tap water consumption 
 
 
• Details of the biomonitoring analyses (complete table with heavy metal, medium, 
person, timing, and rough number analysed): 
 
Type of heavy metal 
assessment 
Pregnancy (mother) Post natal (child) 
Metals Medium 1st trim. 2nd trim. 3rd trim. 
Birth 
(mother or 
child) Age Number 
       
        
        
        
Completed:       
       
       
       
       
Planned:       
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B6. Pesticides  
 
• Was exposure to pesticides assessed for the members of your cohort? 
 yes 
 not yet, but planned. Please give predicted year of completion: 20________   
 no (please proceed to part B7) 
 
Assessment of exposure at individual level 
• Which type of assessment was/will be used?  
 biological sampling 
 questionnaire data on self-reported pesticide use (in home) 
 occupational exposure  
 dietary exposure  
 environmental survey (dust, etc…) 
 other: _________________ 
 
• Details of the assessments (complete table with pesticides type, medium, person, 
timing, and rough number of assessments): 
Type of pesticide assessment Pregnancy (mother) Post natal (child) 
Pesticide Medium 1st trim. 2nd 
trim. 
3rd trim. 
Birth 
(mother or 
child) 
Age Number 
       
        
        
        
        
Completed:       
        
        
        
        
Planned:       
        
 
Assessment of exposure at a geographical level: 
• Which type of assessment was/will be used?  
 land/crop data:  
 geographical scale (national, regional, etc.): ____________________ 
years available (relevant to your cohort): ____________________ 
 pesticide usages in crops: 
 official recommendations or real uses: ____________________ 
 geographical scale (national, regional, etc.): ____________________ 
years available (relevant to your cohort): ____________________ 
 drinking water contamination: 
 groups of pesticides: ____________________ 
frequency (yearly, monthly, etc.): ____________________ 
 air measurements: 
 groups of pesticides: ____________________ 
frequency (yearly, monthly, etc.): ____________________ 
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B7. Radiations: EMF/UV/ionising  
 
• Were any of the following sources of non-ionising or ionising radiation exposure 
assessed for the members of your cohort? 
 power lines 
 mobile phone handsets (use of a mobile phone) 
 mobile phone base stations 
 other RF exposures such as WiFi, cordless phones 
 occupational EMF exposure 
 sun (sun bathing, sun beds, application of protection creams, etc) 
 medical ionising radiation exposures (CT scans, X-rays, interventional cardiology 
procedures) 
 residential radon exposure 
 not yet, but planned. Please give predicted year of completion for the specific exposure:  
 no (proceed to part B8) 
 
• Which type of assessment was/will be used? (copy for each exposure source separately) 
 personal monitors 
 environmental measurements 
 questionnaire data  
 geographical data on source location (for power lines, mobile phone base stations, radon)  
 individual data from mobile phone network operators 
 occupational exposure / JEM 
 
• Details of the assessments (complete table with type of assessment, person, timing, 
and rough number of assessments): 
 
Type of assessment Pregnancy (mother) Post natal (child) 
Exposure Method 1st trim. 2nd 
trim. 
3rd trim. 
Birth 
(mother or 
child) 
Age Number 
       
        
Completed:        
        
        
        
        
Planned:       
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B8. Smoking and Second-hand Smoke (SHS)  
 
A. Active smoking of the mother 
 
• Was exposure to active tobacco smoke assessed for the members of your cohort? 
 yes 
 not yet, but planned. Please give predicted year of completion: 20________   
 no (proceed to second-hand smoke) 
 
• Which type of assessment was used for verifying active smoking (of the mother)?  
 biological sampling  
 questionnaire data (self report) 
 other:_________________ 
 
• If biomarkers were used to verify active smoking status, if known, what was the cut-
off used?  
 serum cotinine > _____ ng/ml 
 urinary cotinine > ______ ng/ml 
 
• If questionnaires were used, which of the following information is available:  
 number of cigarettes smoked per day/week/month  
 at one point during pregnancy  
 at different time points during pregnancy 
 before pregnancy  
 time (week/month) before conception at which mother quit smoking 
 time (week/month) during pregnancy at which mother quit smoking 
 other:_________________ 
 
 
B. Passive smoking / second-hand smoke (SHS) 
 
• Was exposure to passive tobacco smoke / environmental tobacco smoke /second hand 
smoke (SHS) assessed for the members of you cohort? 
 yes 
 not yet, but planned. Please give predicted year of completion: 20________   
 no (proceed to part B9) 
 
• For which members of your cohort did you collect information of exposure to SHS?  
 pregnant women 
 children, age:    
 other: ____________________ 
 
• Which type of assessment was used for evaluating exposure to SHS (mother/child)?  
 biological sampling (i.e cotinine, NNAL) 
 environmental measurements (nicotine dosimeters, indoor PM 2.5 monitors, dust swipes) 
 questionnaire data (who smokes at home, at work, visiting smoky places) 
 other:_________________ 
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• Details of the active and passive smoking assessments (complete table with type, 
method, person, timing, and rough number of assessments): 
 
Type of smoking assessment Pregnancy (mother) Post natal (child) 
Compound Medium 1st trim. 2nd trim. 3rd trim. 
Birth 
(mother or 
child) 
Age Number 
Completed:       
NNAL        
Cotinine        
Maternal smoking        
Smoking in home        
Smoking in 
working place 
 
      
Smoking in 
bars/cafes (before 
ban of tobacco 
smoke) 
 
      
        
Planned:       
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B9. Noise  
 
• Was noise exposure assessed for the members of your cohort? 
 yes 
 not yet, but planned. Please give predicted year of completion: 20____  
 no (proceed to part B10) 
 
A. Objective assessment 
 
• Was noise data collected by objective assessments – noise measurements or noise 
maps? 
 yes 
 no 
- If yes please provide details:  ________________________ 
 
 
B. Passive assessment 
 
• Was noise data collected by subjective assessments? 
 yes: participants were asked for subjective description of noise exposure:  
   at home 
    during day 
    at night 
   roads/traffic 
   airplanes 
   other: __________________ 
 yes: personal feeling of noise annoyance/disturbance (degree with Likert scale etc) 
 no 
 
• Details of the noise assessments (complete table with type of assessment, timing, and 
rough number of assessments): 
Type of noise assessment Pregnancy (mother) Post natal (child) 
Noise Type of 
measurement 
1st trim. 2nd 
trim. 
3rd trim. 
Birth 
(mother or 
child) 
Age Number 
       
        
        
Completed:       
        
        
        
        
        
Planned:       
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B10. POPs  
 
• Was exposure to POPs (PCBs, dioxins, etc.) assessed in biological samples for the 
members of your cohort?  
 yes 
 not yet, but planned. Please give predicted year of completion: 20_____   
 no (proceed to part B11) 
 
• Which (groups of) POPs were assessed? 
 aldrin 
 chlordane 
 DDT and metabolites 
 dieldrin and endrin 
 heptachlor 
 hexachlorobenzene 
 mirex 
 polychlorinated biphenyls  
 polychlorinated dibenzo-p-dioxins 
 polychlorinated dibenzo furans 
 toxaphene 
 brominated  flame retardants 
 flourinated compounds 
 organometallic compunds (TBT) 
 other: _________________________________ 
 
• Details of the assessments (complete table with POP type, medium, person, timing, 
and rough number of assessments): 
Type of POP assessment Pregnancy (mother) Post natal (child) 
POPs Medium 1st trim. 2nd 
trim. 
3rd trim. 
Birth 
(mother or 
child) 
Age Number 
       
        
        
Completed:       
        
        
        
Planned:       
        
        
        
 
• Was fatty acids measured in the blood samples? 
 yes, specify which _________________ 
 no 
 not yet, but planned 
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B11. Occupation  
 
• B11a. Was occupational history collected for the members of your cohort? 
 yes 
 not yet, but planned. Please give predicted year of completion: 20_____   
 no (proceed to B11.b) 
 
• Please tick below the periods for which this data was collected and whether it is 
available for mother and father? Please indicate whether data was collected 
prospectively or retrospectively? 
 
 
 
• Indicate below the codes used for recording occupation and industrial activity in 
your cohort: 
 occupation (ie ILO 1968, or national coding system):  _________________ 
 industrial activity (ie ISIC 1971):  
 no coding, but checklist of occupations 
 no coding, but recording of job title and/or task performed 
 
 
• B11.b Was any specific occupational exposure assessed?  
 yes 
 not yet, but planned. Please give predicted year of completion: 20_____   
 no  
 
• If yes, specify the list of occupational exposures assessed (ie solvents, hair sprays, 
mercury, endocrine disruptors, etc…): 
___________________________________________________________________________
___________________________________________________________________________ 
 
• Which type of assessment was used? (copy the section for each category of exposure): 
 biological sampling 
 environmental sampling 
 questionnaires on specific exposures or jobs (e.g. health care workers, hairdressers,     
      agriculture, etc)  
 Job Exposure Matrix (JEM) 
 expert judgment 
 other:_________________ 
Pregnancy   Before 
pregnancy 1st trimester 2nd trimester 3rd trimester 
Retrospective or 
prospective 
Timing of the 
questionnaire 
       
Mother       
Father       
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• Please provide details for the specific occupational exposures. Please indicate 
whether data was collected prospectively or retrospectively? 
 
 
 
 
 
 
 
 
B11c. Other data available at a national level: 
• Are you aware of any JEMs built in your country in the recent period (covering the 
enrolment period of your cohort)? 
 yes  
 no (please proceed to part B12) 
 
• Which exposures were assessed? 
______________________________________________________________________ 
• Which coding system was used? 
________________________________________________________________________ 
 
• Please give a reference or report number describing these JEMs: 
___________________________________________________________________________
___________________________________________________________________________  
 
 
Assessment Before 
pregnancy 
Pregnancy  
  1st trimester 2nd trimester 3rd trimester 
Retrospective 
or 
prospective 
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B12. Other chemical exposures: e.g. BPA, phthalates, etc. 
 
• Was exposure to any other chemicals assessed for the members of you cohort? 
 yes 
 not yet, but planned. Please give predicted year of completion: 20_____ 
 no 
 
• Which agents were/will be assessed? 
 bisphenol A 
 phthalates  
  
  
  
 
• Which type of assessment was used?  
 biological sampling 
 environmental sampling (dust, etc…) 
 questionnaire data (use of hair sprays, cosmetics, food containers,...), please 
specify__________ 
 occupational exposure / JEM 
 dietary exposure  
 other: _________________ 
 
• Details of the assessments (complete table with type of substance, medium, person, 
timing, and rough number of assessments): 
Type of assessment Pregnancy (mother) Post natal (child) 
Pesticide Medium 1st trim. 2nd 
trim. 
3rd trim. 
Birth 
(mother or 
child) 
Age Number 
       
        
        
Completed:       
        
        
Planned:       
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C. Health Outcome Assessment 
 
C1. Reproduction and Birth outcomes  
 
• Was data on reproductive and birth outcomes collected for the members of your 
cohort? 
 yes 
 not yet, but planned. Please give predicted year of completion: 20____  
 no (proceed to part C2) 
 
 
• Use of a contraceptive method at the start of a pregnancy: 
 yes 
 not yet, but planned. Please give predicted year of completion: 20_____   
 no 
 
• Time to pregnancy: 
 yes 
 not yet, but planned. Please give predicted year of completion: 20_____   
 no 
 
• Infertility treatment before the index pregnancy: 
 yes 
 not yet, but planned. Please give predicted year of completion: 20_____   
 no 
If yes, was the duration of the pregnancy attempt until the start of the infertility treatment 
recorded?  yes 
 no 
 
 
• Congenital anomalies: 
 yes. Please give %/number of subjects for whom this information was collected: _____ 
 not yet, but planned. Please give predicted year of completion: 20_____   
 no 
 
• Specific anomalies of the male reproductive system:  
 yes.  
 cryptorchidism (if planned, year _____) 
 hypospadias (if planned, year _____) 
 anogenital distance (if planned, year _____) 
 no 
 
 
• Spontaneous abortions (until 21 weeks of amenorrhea) 
 yes. Please give %/number of subjects for whom this information was collected: _____ 
 not yet, but planned. Please give predicted year of completion: 20_____   
 no 
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• Stillbirths (after 22 weeks of amenorrhea)  
 yes. Please give %/number of subjects for whom this information was collected: _____ 
 not yet, but planned. Please give predicted year of completion: 20_____   
 no 
 
• Medical termination of pregnancy  
 yes. Please give %/number of subjects for whom this information was collected: _____ 
 not yet, but planned. Please give predicted year of completion: 20_____   
 no 
If yes, please indicate if information on the reason of the termination of the pregnancy is 
known, and if the presence of congenital malformations has been recorded. 
_______________________________________________________________________ 
 
• Birth weight  
 yes. Please give %/number of subjects for whom this information was collected: _____ 
 not yet, but planned. Please give predicted year of completion: 20_____   
 no 
If yes, please indicate how the data were collected:  
  Self-reported from mothers 
  Medical record, midwife or doctor reported 
  Other, specify__________________________  
 
• Gestational Duration 
 yes. Please give %/number of subjects for whom this information was collected: _____ 
 not yet, but planned. Please give predicted year of completion: 20_____   
 no 
If yes, what is the origin for the calculation of gestational duration? 
 self-reported last menstrual period (by study subject) 
 Medical record: midwife or physician assessed last menstrual period (on basis of self-
report, but assessed and recorded by medically qualified person) 
 ultrasound  
 other: 
 
• Premature Rupture of Membranes  
 yes. Please give %/number of subjects for whom this information was collected: _____ 
 not yet, but planned. Please give predicted year of completion: 20_____   
 no 
 
• Onset of labour (spontaneous, induced, caesarean section before onset, ...)  
 yes. Please give %/number of subjects for whom this information was collected: _____ 
 not yet, but planned. Please give predicted year of completion: 20_____   
 no 
 
• Mode of delivery (spontaneous vaginal birth, operative vaginal birth, caesarean 
section) 
 yes. Please give %/number of subjects for whom this information was collected: _____ 
 not yet, but planned. Please give predicted year of completion: 20_____   
 no 
 
• Ultrasound measurements 
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 yes. Please give %/number of subjects for whom this information was collected: _____ 
 not yet, but planned. Please give predicted year of completion: 20_____   
 no 
If yes, describe how many ultrasounds, which gestational weeks: 
 
• Doppler measurements (of uterine, umbilical, fetal cervical arteries, or other) 
 yes. Please give %/number of subjects for whom this information was collected: _____ 
 not yet, but planned. Please give predicted year of completion: 20_____   
 no 
If yes, describe the arteries concerned, which gestational weeks, how many (or percentage of) 
women: 
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C2. Neurodevelopment  
 
• Was data on neurodevelopmental and behavioural outcomes collected for the 
members of your cohort? 
 yes 
 not yet, but planned. Please give predicted year of completion: 20____  
 no (proceed to part C3) 
 
• Which of the following outcomes were assessed in the children: 
 neuropsychological assessment (e.g. developmental tests for executive function, memory,      
      language, IQ) 
 behaviour (ADHD symptoms, etc) 
 autism symptoms 
 school achievements/performance 
 neurophysiology/neuroimaging: _______________ 
 other:_____________________________________ 
 
• Details of neurobehavioural and cognitive development assessment of child (number 
completed or planned) 
Post natal (give months/years of age) Name of test/assessment and year 
(Bayley, McCarthy, Griffith, ...) 
Birth 
e.g. 14 
months 
 4 years   
Dubowitz       
Bayley scales of infant development 
(BSID)       
Griffiths Mental Development 
scales        
McCarthy scales of children’s 
abilities (MSCA)       
Wechsler Preschool and Primary 
scale of Intelligence (WPPSI)       
Others:       
       
       
       
 
 
• Which of the following assessments were completed in mothers and fathers: 
Type of assessment  Name of test Timing Number/% of 
cohort 
maternal IQ 
  
  
paternal IQ 
 
 
 
maternal mental health 
 
 
 
paternal mental health 
 
 
 
maternal stress 
 
 
 
Paternal stress 
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maternal attachment 
  
  
paternal attachment 
  
  
Other 
  
  
    
 
 
 
 
 
  
 
23
C3. Allergies and Asthma  
 
• Was data on asthma and allergies collected for the members of your cohort? 
 yes 
 not yet, but planned. Please give predicted year of completion: 20____  
 no (proceed to part C4) 
 
• Which of the following outcomes were assessed in the children: 
 asthma 
 allergies (other than allergic rhinitis) 
 allergic rhinitis (indoor/outdoor) 
 eczema  
 respiratory infections (upper/lower) 
 food allergies 
 
Asthma 
• Which of the following methods to assess asthma were used? 
 parental questionnaires / interview (wheezing, asthma symptoms) 
 doctor´s diagnosis of asthma (by study doctor or parent-reported doctor´s diagnosis) 
 lung function tests 
 oscilometry 
 spirometry 
 bronchial challenge test 
 tested reversibility (bronchodilators) 
 interrupter technique (Rint)  
 exhaled NO 
 
Allergic Rhinitis 
• Which of the following methods to assess allergies were used? 
 parental questionnaires/ interview  (sneezing, runny nose, nasal congestion, itching of the 
nose, and post nasal drip) 
 doctor´s diagnosis of allergy  (by study doctor or parent-reported doctor´s diagnosis) 
 sensitization assessment  (blood samples, SPT (skin prick test), urine samples) 
 
Eczema 
• Which of the following methods to assess eczema were used? 
 parental questionnaires/ interview   
 doctor´s diagnosis of allergy  (by study doctor or parent-reported doctor´s diagnosis) 
 
 
Allergic Sensitization Assessment  
• Were IgE-antibodies to common inhalant allergens analysed in biological samples? 
 yes 
 no 
If yes, describe the specific IgE measured: 
   total IgE 
   IgE mite 
   IgE cat 
   IgE dog 
   IgE pollen 
  IgE grass 
  other, including food allergies 
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• Were skin prick tests (SPT) performed? 
 yes 
 no 
If yes, indicate the specific SPT performed: 
   mite 
   cat 
   dog 
   pollen 
   mould 
             others, including food allergens 
 
 
• Details of asthma and allergy assessment of child (number completed or planned) 
Type of assessment and timing Post natal (give months/years of age) 
Outcome Method 
Birth 
   Number/% of 
cohort 
       
       
       
       
       
       
       
       
       
       
       
       
Completed:       
       
       
       
Planned:       
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C4. Cancer  
 
• Is information on childhood cancers collected for your cohort 
 yes 
 not yet, but planned. Please give predicted year of completion: 20_____   
 no 
 
• Please describe how: 
 linkage to cancer registry 
 other: ________________________________ 
 
• What is the estimated annual number of childhood cancer cases in your cohort 
0-1 years:  _________________ 
1-2 years:  _________________ 
2-5 years:  _________________ 
5-10 years:  _________________ 
10-15 years:  _________________ 
15-18 years:  _________________ 
 (or other, convenient, age categories) 
 
• Are genotoxicity markers measured in your cohort? 
 yes 
 not yet, but planned. Please give predicted year of completion: 20_____   
 no 
 
Details?  
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C5. Childhood growth and obesity, sexual maturation, other outcomes 
 
• Is information on childhood growth, obesity, sexual maturation, or other metabolic 
and endocrine disorders, collected for your cohort? 
 yes 
 not yet, but planned. Please give predicted year of completion: 20_____   
 no, please go to section D 
 
• Which of the following outcomes were assessed in the children: 
 childhood growth and obesity 
 indicators of metabolic syndrome 
 diabetes 
 sexual maturation 
 other:_____________________________________ 
 
• Details of childhood growth and obesity assessments (give number/% completed or 
planned) 
Post natal (give months/years of age) Measure of 
growth/ body 
composition 
Type of assessment 
(self-report, medical 
record, measurement, 
etc) 
Birth 
     
Weight        
Height        
Waist 
circumference 
  
     
Arm 
circumference 
  
     
Wrist 
circumference 
  
     
Fat/fat free 
mass by 
bioimpedance 
  
     
Other measure 
of body 
composition: 
  
     
        
 
 
• Details of metabolic syndrome indicator assessments in children (give number/% 
completed or planned) 
Post natal (give months/years of age) Indicator Type of assessment 
(include whether 
fasting samples...) 
Birth 
     
Blood pressure        
Cholesterol        
Cholesterol        
Triglycerides        
Glucose        
Insulin        
Other:        
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• Details of sexual maturation assessments (give number/% completed or planned) 
Post natal (give years of age) Measure Type of assessment 
(self-reported 
child/mother, evaluated 
by doctor,...) 
Birth 
     
Tanner stage        
Puberal 
Development 
Stage 
  
     
Age at        
Age at voice 
change 
       
Gonadal axis 
hormones 
       
Other:        
        
        
        
 
 
• Other outcome assessments, including other biomarkers of effect (e.g. thyroid 
hormones, CRP, etc) 
Post natal (give months/years of age) Measure Type of 
assessment 
Prenatal 
(mother) 
At birth
     
         
         
         
         
         
         
         
         
 
  
 
28
D. Other information – including genetic and important covariates - all please comment 
 
D1. Genotyping: 
• Have genetic analyses been performed  
 yes, GWAS 
 yes, specific genes: ________________________________________________________ 
 not yet, but planned. Please give predicted year of completion: 20_____   
 no 
 
D2. Residential history and time-activity (tick which are available) 
• Home addresses available: 
 only once: 
 during pregnancy 
 at birth 
 during follow-up: week/month:_________________ 
 residential history 
 
• Work addresses of mother during pregnancy: 
 yes 
 no 
 
• School/daycare addresses of child 
 yes 
 no 
 
• Were these addresses geocoded? 
 yes, specify which _________ 
 not yet, but planned. Please give predicted year of completion: 20_____   
 no  
 
D3. Time activity patterms 
• Was information on time-activity patterns collected: 
 for child  
 questionnaire, specify when _________ 
 diary, specify when ____________ 
 for mother  
 questionnaire, specify when _________ 
 diary, specify when ____________ 
 
D4. Sociodemographic variables  
 mother’s social class (coded from occupation), specify coding system ___________ 
 father’s social class (coded from occupation), specify coding system ____________ 
 household income 
 mother’s education 
 father’s education 
 mother’s ethnic origin/country of birth 
 father’s ethnic origin/country of birth 
 maternal age 
 paternal age 
 parity 
 birth order 
 child’s sex  
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D5. Breastfeeding 
 weeks of breastfeeding 
 weeks of exclusive breastfeeding 
 
D6. Diet and physical exercise 
• Dietary assessments 
 yes:  
 FFQ 
 24 hour recall 
 other: ______________________________ 
person (child/mother): _________________________________________________ 
timing (e.g. stage of pregnancy, age of child): _______________________________ 
 no 
 
• Assessment of physical exercise: 
 yes:  
 questionnaire 
 measurements 
person (child/mother): _________________________________________________ 
timing: __________________________________________________ 
 no 
 
D7. Medical history 
• Is the following information collected for the parents? 
 family history 
 pre-pregnancy medical history of mother 
 pregnancy complications 
           blood pressure measurements 
                      maternal hypertension 
                      preeclampsia 
 maternal allergic history 
 paternal allergic history 
 
D8. Parental anthropometry 
 maternal pre-pregnancy weight, height  
 maternal pregnancy weight, height  
 paternal weight/height 
 
D9. Other/Comments 
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Annex 2: Assessment of birth outcomes in European birth cohorts participating in ENRIECO a 
 
Table 1. Reproductive and birth outcomes a (* indicates that measurements are planned or ongoing but not completed).  
Cohort Time to 
pregnancy 
Congenital 
anomalies 
Spontaneous 
abortion/stillbirths/terminations 
Gestational 
age 
Birth 
weight 
Mode of 
delivery 
Ultrasound 
measurements 
ABCD X X X X X X  
ALSPAC X X X X X X X 
ArcRisk-Norway X X  X X X X 
BAMSE X   X X X  
BiB  X  X X X X 
Co.N.ER X X X X X X  
Czech X X X X X X  
DARC    X X X  
DNBC X X X X X X X 
Duisburg  X  X X X  
EDEN X X X X X X X 
ELFE X* X* X* X* X* X* X* 
Faroes X X X X X X X 
FLEHS I X  X X X X  
GASPII    X X X  
Generation R X X X X X X X 
Generation XXI X X  X X X X 
GINIplus    X* X X*  
HUMIS X X X X X X X 
INMA old X X X X X X  
INMA new X X X X X X X 
INUENDO X X* X X X   
KANC X X*  X X  X 
KOALA X X  X X X  
Krákow  X  X X X  
Leicester    X X X*  
LISAplus    X X X  
LUKAS    X X X  
MAS    X X X  
MoBa X X X X X X X 
NINFEA X* X*  X* X* X*  
PARIS X  X* X X X  
PCB cohort   X X X X  
PELAGIE X X X X X X  
PIAMA    X X X  
REPRO_PL  X X X X X X 
RHEA X  X X X X X 
a Details of each assessment (method, time period, number of subjects) are available on www.birthcohortsenrieco.net (Inventory of ENRIECO Cohorts 2011).  
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Table 2. Neurodevelopment outcomes a (* indicates that measurements are planned or ongoing but not completed).  
Cohort Cognitive function Behaviour Autism symptoms Hyperactivity disorders School achievements/performance Mental health Personality 
ABCD X* X  X* X*   
ALSPAC X X X X X X X 
ArcRisk-Norway        
BAMSE        
BiB     X*   
Co.N.ER        
Czech         
DARC        
DNBC  X X X X X X 
Duisburg X X  X    
EDEN X X  X    
ELFE X*       
Faroes X X X X X X  
FLEHS I X X X X    
GASPII X X      
Generation R X X X X    
Generation XXI        
GINIplus  X  X    
HUMIS X* X* X* X*    
INMA old X X  X    
INMA new X X* X* X*    
INUENDO    X*    
KANC        
KOALA  X X X X*   
Krákow X X X X    
Leicester         
LISAplus  X X X    
LUKAS        
MAS X       
MoBa X* X* X* X*    
NINFEA X*   X*    
PARIS        
PCB cohort X X X X    
PELAGIE        
PIAMA     X   
REPRO_PL X*       
RHEA X       
a Details of each assessment (method, time period, number of subjects) are available on www.birthcohortsenrieco.net (Inventory of ENRIECO Cohorts 2011). 
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Table 3. Asthma, allergy, and respiratory outcomes, cancer, growth and obesity, metabolic syndrome, sexual maturation a (* indicates that 
measurements are planned or ongoing but not completed).  
Allergies & Asthma Cohort 
Asthma Allergies Allergic 
rhinitis 
Eczema Respiratory 
infections 
Food 
allergies 
Cancer Growth and 
obesity 
Metabolic 
syndrome 
Sexual 
maturation 
ABCD X   X    X X  
ALSPAC X X X X  X X X X X 
ArcRisk-Norway           
BAMSE X X X X X X  X  X 
BiB        X   
Co.N.ER X X X X X X  X   
Czech  X X X  X  X    
DARC X X  X X X  X   
DNBC X  X X X X X X X X 
Duisburg X X X X X X  X  X* 
EDEN X X* X X X X X X X  
ELFE X* X* X* X* X* X* X* X* X* X* 
Faroes X  X X    X X X 
FLEHS I X X X X X   X   
GASPII X X X X X X  X   
Generation R X X  X X X  X X  
Generation XXI X X X X X X X X X  
GINIplus X X X X    X X X 
HUMIS X  X X X X X X   
INMA old X X X X X   X X X* 
INMA new X* X* X* X X X X* X X X* 
INUENDO        X*   
KANC           
KOALA X X X X X X  X X  
Krákow X X  X X   X   
Leicester  X X X X X   X X*  
LISAplus X X X X X X  X X X 
LUKAS X X X X X X  X X X* 
MAS X X X X  X  X  X 
MoBa X  X X X X X X X  
NINFEA X*  X* X* X* X* X* X*  X* 
PARIS X X   X   X   
PCB cohort X X  X  X  X* X*  
PELAGIE X X X X X X  X X  
PIAMA X X X X X X  X X X 
REPRO_PL X X X X X  X X   
RHEA X  X X X X X* X   
a Details of each assessment (method, time period, number of subjects) are available on www.birthcohortsenrieco.net (Inventory of ENRIECO Cohorts 2011). 
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